$SNDX
Syndax Pharmaceuticals, Inc.
XNAS•Health Care•Pharmaceutical Preparations
$17.60
▼-3.40%-$0.620
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateSyndax Pharmaceuticals, Inc.
XNAS•Health Care•Pharmaceutical Preparations
Why is SNDX down today? It is at $17.60 (-3.40%), and our scanner flagged it 75 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment SNDX spikes, and full due diligence on SNDX — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $SNDX 75 times in the last 30 days. Create a free account to track $SNDX, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on SNDX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for SNDX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystSyndax Pharmaceuticals Inc: Q2 FY2026 results, three months to Jun 30, 2026, from an SEC filing. Read it →Latest filingSC 13GPassive 5%+ stake disclosedAug 7, 2026 · 58 days agoSources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Metzger Michael A Officer | Sold (automatic/other) | -32K 0.04% of company | sold 6.3% | 485K | $785K at $24.24 | Jul 8, 26 |
Metzger Michael A Officer | Other | 32K 0.04% of company | added 6.7% | 517K | $207K at $6.38 | Jul 8, 26 |
Botwood Nicholas A.J. Officer | Sold (automatic/other) | -31K 0.03% of company | sold 34% | 61K | $567K at $18.14 | Jun 12, 26 |
Botwood Nicholas A.J. Officer | Other | 31K 0.03% of company | added 51% | 92K | $432K at $13.82 | Jun 12, 26 |
Botwood Nicholas A.J. Officer | Sold (automatic/other) | -34K 0.04% of company | sold 36% | 61K | $617K at $18.00 | Jun 11, 26 |
Botwood Nicholas A.J. Officer | Other | 23K 0.03% of company | added 31% | 95K | $311K at $13.82 | Jun 11, 26 |
Metzger Michael A Officer | Sold (automatic/other) | -7K | sold 1.4% | 485K | $130K at $18.99 | Jun 1, 26 |
Goldan Keith A. Officer | Sold (automatic/other) | -1K | sold 0.8% | 139K | $22K at $18.99 | Jun 1, 26 |
Goldan Keith A. Officer | Sold (automatic/other) | -3K | sold 2.4% | 140K | $72K at $21.03 | Feb 9, 26 |
Metzger Michael A Officer | Sold (automatic/other) | -17K 0.02% of company | sold 3.4% | 492K | $361K at $21.03 | Feb 9, 26 |
Goldan Keith A. Officer | Sold (automatic/other) | -2K | sold 1.4% | 144K | $43K at $20.62 | Feb 6, 26 |
Metzger Michael A Officer | Sold (automatic/other) | -7K | sold 1.4% | 509K | $153K at $20.62 | Feb 6, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on SNDX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for SNDX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
SNDX last traded at $17.60, down 3.40% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Syndax Pharmaceuticals, Inc. (SNDX) is next expected to report earnings on Monday, November 2, 2026, about 29 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The SNDX Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged SNDX 75 times in the last 30 days.
SNDX (Syndax Pharmaceuticals, Inc.) trades on XNAS, with a market cap of about $1.57B in the PHARMACEUTICAL PREPARATIONS sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge SNDX for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$SNDX discussion
Sign in to ask a question or join the discussion.